Free Trial

Crinetics Pharmaceuticals (CRNX) Earnings Date, Estimates & Call Transcripts

$47.17
-0.30 (-0.63%)
(As of 12:09 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 9)
-$0.93 Missed By -$0.09
Consensus EPS
(May. 9)
-$0.84
Skip Charts & View Estimated and Actual Earnings Data

CRNX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRNX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Crinetics Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)($0.68)($0.76)
Q2 20242($0.86)($0.71)($0.79)
Q3 20242($0.90)($0.74)($0.82)
Q4 20242($0.90)($0.77)($0.84)
FY 20248($3.50)($2.90)($3.20)

CRNX Earnings Date and Information

Crinetics Pharmaceuticals last posted its quarterly earnings results on May 9th, 2024. The reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.84) by $0.09. The business earned $0.64 million during the quarter, compared to analyst estimates of $0.20 million. Its revenue was down 76.1% compared to the same quarter last year. Crinetics Pharmaceuticals has generated ($3.78) earnings per share over the last year (($3.78) diluted earnings per share). Earnings for Crinetics Pharmaceuticals are expected to decrease in the coming year, from ($3.53) to ($3.78) per share. Crinetics Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Crinetics Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/9/2024Q1 2024($0.84)($0.93)($0.09)($0.93)$0.20 million$0.64 million    
2/28/2024Q4 2023($0.89)($0.90)($0.01)($0.90)$0.20 million-    
11/7/2023Q3 2023($0.89)($1.01)($0.12)($1.01)-$0.35 million
8/8/2023Q2 2023($0.85)($0.94)($0.09)($0.94)$5.00 million$0.99 million
5/4/2023Q1 2023($0.82)($0.85)($0.03)($0.85)$0.63 million$2.68 million
2/28/2023Q4 2022($0.82)($0.84)($0.02)($0.84)$0.75 million$0.71 million
11/14/2022Q3 2022($0.78)($0.78)-($0.78)$1.00 million$0.46 million
8/12/2022Q2 2022($0.62)($0.81)($0.19)($0.81)$1.80 million$0.44 million
5/12/2022Q1 2022($0.56)($0.73)($0.17)($0.73)-$3.13 million
3/30/2022Q4 2021($0.57)($0.68)($0.11)($0.68)-$1.08 million
11/5/2021Q3 2021($0.72)($0.73)($0.01)($0.73)--    
8/9/2021Q2 2021($0.61)($0.70)($0.09)($0.70)--
5/6/2021Q1 2021($0.66)($0.69)($0.03)($0.69)--  
3/29/2021Q4 2020($0.58)($0.66)($0.08)($0.66)--  
11/11/2020Q3 2020($0.53)($0.56)($0.03)($0.56)--  
8/7/2020Q2 2020($0.55)($0.53)+$0.02($0.53)--
5/8/2020Q1 2020($0.63)($0.71)($0.08)($0.71)-$0.07 million
3/9/2020Q4 2019($0.68)($0.60)+$0.08($0.60)$0.30 million$0.32 million
11/12/2019Q3 2019($0.5680)($0.60)($0.0320)($0.60)$0.33 million$0.51 million
8/13/2019Q2 2019($0.4560)($0.51)($0.0540)($0.51)$0.33 million-

Crinetics Pharmaceuticals Earnings - Frequently Asked Questions

When is Crinetics Pharmaceuticals's earnings date?

Crinetics Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on CRNX's earnings history.

Did Crinetics Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) missed the analysts' consensus estimate of ($0.84) by $0.09 with a reported earnings per share (EPS) of ($0.93). Learn more on analysts' earnings estimate vs. CRNX's actual earnings.

How can I listen to Crinetics Pharmaceuticals's earnings conference call?

The conference call for Crinetics Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Crinetics Pharmaceuticals's conference call transcript?

The conference call transcript for Crinetics Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Crinetics Pharmaceuticals generate each year?

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded annual revenue of $4.01 million.

How much profit does Crinetics Pharmaceuticals generate each year?

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded net income of -$214.53 million. CRNX has generated -$3.78 earnings per share over the last four quarters.

What is Crinetics Pharmaceuticals's EPS forecast for next year?

Crinetics Pharmaceuticals's earnings are expected to decrease from ($3.53) per share to ($3.78) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CRNX) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners